CCR5 and infection: Preexisting resistance to MVC observed in TF viruses could be explained as a result of adaptive variations in gp120 that abrogates binding of the active form of the CCR5 antagonist34, or the possible use of alternate co-receptors for infection by the viral isolates present in the early stages of infection35,36.